tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TBPH is currently covered by 3 analysts with an average price target of $18.13. This is a potential upside of $6.88 (61.16%) from yesterday's end of day stock price of $11.25.
Theravance Biopharma's activity chart (see below) currently has 79 price targets and 60 ratings on display. The stock rating distribution of TBPH is 70% BUY and 30% HOLD.
Analysts average stock forecasts to be materialized ratio is 37.6% with an average time for these price targets to be met of 109.75 days.
Highest price target for TBPH is $15, Lowest price target is $9, average price target is $11.33.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 27-Feb-2025. First documented stock forecast 03-Feb-2015.
Currently out of the existing stock ratings of TBPH, 7 are a BUY (70%), 3 are a HOLD (30%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$5.84 (63.76%)
$15
3 months 10 days ago
(27-Feb-2025)
3/16 (18.75%)
$5.73 (61.81%)
35
Hold
$9
$-0.16 (-1.75%)
$10
10 months ago
(06-Aug-2024)
4/6 (66.67%)
$1.17 (14.94%)
96
Hold
$10
$0.84 (9.17%)
$14
10 months ago
(06-Aug-2024)
1/3 (33.33%)
$2.17 (27.71%)
126
Sell
$10
$0.84 (9.17%)
$10
2 years 10 months 12 days ago
(25-Jul-2022)
2/8 (25%)
$0.76 (8.23%)
70
Buy
$12
$2.84 (31.00%)
3 years 14 days ago
(23-May-2022)
3/8 (37.5%)
$2.6 (27.66%)
85
What is TBPH (Theravance Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on TBPH (Theravance Biopharma) with a proven track record?
Which analyst has the most public recommendations on TBPH (Theravance Biopharma)?
Which analyst is the currently most bullish on TBPH (Theravance Biopharma)?
Which analyst is the currently most reserved on TBPH (Theravance Biopharma)?
